Why did BAYN.SW stock rise today?

BAYN.SW stock rose **6.57%** intraday on **21 Jan 2026** due to sector strength, short-covering and pre-earnings positioning. Low traded volume suggests moves were trader-driven rather than broad institutional flows.

What is Meyka AI’s rating for BAYN.SW stock?

Meyka AI rates BAYN.SW **63.62/100 (B, HOLD)**. The grade uses benchmark, sector, financial growth, key metrics and forecasts. Grades are informational and not investment advice.

What price targets apply to BAYN.SW stock?

We outline a conservative target **CHF42.00**, base **CHF48.00**, and bull **CHF57.00**. Meyka AI’s 1-year model projects **CHF56.80**, implying roughly **+42.86%** upside from **CHF39.77**.

What are the main risks for BAYN.SW stock?

Key risks for BAYN.SW stock include margin pressure, regulatory or litigation outcomes, slower product launches, and currency headwinds. Interest coverage (**2.73**) and liquidity trends deserve watchful attention.

CH Stocks

BAYN.SW Bayer AG (SIX) up 6.57% intraday 21 Jan 2026: watch CHF39.77 breakout

ByDanny Kontos January 21, 2026January 21, 2026

BAYN.SW stock led Swiss healthcare gainers today, climbing 6.57% to CHF39.77 on the SIX intraday session of 21 Jan 2026. Volume was light at 4.00 shares versus a 50-day average of 272.00, but the price jump closed above the 50/200-day average of CHF36.83, signalling a short-term technical shift. Traders cited sector strength and renewed appetite ahead of Bayer’s next earnings date. We examine valuation, catalysts, Meyka AI grading, and a concise outlook for BAYN.SW stock activity today.